Omicron may not evade all monoclonal antibodies, lab study suggests Press Trust of India Jan 26, 2022 Several past studies have shown that such antibodies are unsuccessful in neutralising Omicron
Virtual clinical trials would have a tremendous advantage in expanding the reach of clinical trials Viveka Roychowdhury Jan 2, 2021 Suneela Thatte, VP and Head - R&D Solutions India, IQVIA speaks on the challenges faced by CROs due to the pandemic, the…
AbbVie, Amgen and Takeda jointly study impact of anti-inflammatory drugs in COVID-19 treatment EP News Bureau Aug 4, 2020 I-SPY COVID will evaluate the impact of cenicriviroc, otezla, and firazyr on inflammatory response in severely ill, hospitalised…
